本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2012/6/81 分钟阅读
Determination of Regulatory Review Period for Purposes of Patent Extension; KALBITOR; Correction
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of May 2, 2012 (77 FR 26017). The document concerned FDA's determination of the regulatory review period for KALBITOR. The document published with an incorrect patent number for KALBITOR. This document corrects that error.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →